Group 1 - BioLife Solutions, Inc. (BLFS) closed at $22.03, with a 3.2% gain over the past four weeks, and a mean price target of $31.22 indicating a 41.7% upside potential [1] - The average of nine short-term price targets ranges from $30 to $34, with a standard deviation of $1.48, suggesting a low variability among analysts [2] - Analysts are optimistic about BLFS's earnings prospects, with a significant increase in the Zacks Consensus Estimate for the current year by 123.1% [12] Group 2 - The Zacks Rank for BLFS is 1 (Strong Buy), placing it in the top 5% of over 4,000 ranked stocks based on earnings estimates [13] - Analysts' agreement on higher earnings estimates is a strong indicator of potential stock price movements, as empirical research shows a correlation between earnings estimate revisions and stock price changes [11] - While price targets are often viewed skeptically, the direction they imply for BLFS appears to be a good guide for potential upside [10][13]
How Much Upside is Left in BioLife Solutions (BLFS)? Wall Street Analysts Think 41.72%